{"nct_id":"NCT03778229","title":"Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-05","start_date":"2019-01-09","start_date_type":"ACTUAL","primary_completion_date":"2024-08-23","primary_completion_date_type":"ACTUAL","completion_date":"2025-05-28","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}